Abstract
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/140886247
Article citations
Risk stratification and treatment goals in pulmonary arterial hypertension.
Eur Respir J, 64(4):2401323, 31 Oct 2024
Cited by: 2 articles | PMID: 39209472 | PMCID: PMC11525341
Review Free full text in Europe PMC
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools.
ERJ Open Res, 10(4):225-2024, 01 Jul 2024
Cited by: 1 article | PMID: 39104950 | PMCID: PMC11298999
Stem cell therapy in pulmonary hypertension: current practice and future opportunities.
Eur Respir Rev, 32(169):230112, 27 Sep 2023
Cited by: 2 articles | PMID: 37758272 | PMCID: PMC10523152
Review Free full text in Europe PMC
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Unsolved Issues on Beneficial Effects of Combination Therapy With Sotatercept in Pulmonary Arterial Hypertension.
Heart Lung Circ, 33(1):12-13, 30 Nov 2023
Cited by: 1 article | PMID: 38040502
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.
Eur Respir J, 61(1):2201347, 06 Jan 2023
Cited by: 31 articles | PMID: 36041750 | PMCID: PMC9816418
Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial.
Cardiovasc Res, 119(16):e155-e157, 01 Dec 2023
Cited by: 1 article | PMID: 37584249
Sotatercept: First Approval.
Drugs, 84(7):857-862, 21 Jun 2024
Cited by: 0 articles | PMID: 38904927
Review